Trial · NCT04273139
Outcomes15
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Very Good Partial Response Within 24 Cycles of Therapy | The primary objective of VGPR within 24 cycles of therapy was assessed starting at Cycle 3 Day 1 through the End of Treatment visit, range of 2 to 21 months after the initiation of therapy. | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Complete Response (CR) After 6 Cycles | 6 Cycles (28 day cycle) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Complete Response (CR) After 12 Cycles | 12 Cycles (28 day cycle) | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Complete Response (CR) After 24 Cycles | Complete response to therapy was assessed starting at Cycle 3 Day 1 through the End of Treatment visit, range of 2 to 21 months after the initiation of therapy. | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Overall Response | 72 months | |||
| SECONDARY | Rate of VGPR at 30 Months | 30 Months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Median Time to Response | 24 months | months | MEDIAN | |
| SECONDARY | Median Time to Major Response | 24 months | months | MEDIAN | |
| SECONDARY | Progression Free Survival (PFS) at 24 Months | 24 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Progression Free Survival (PFS) at 36 Months | 36 Months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Progression Free Survival (PFS) at 48 Months | 48 Months | |||
| SECONDARY | Progression Free Survival (PFS) at 60 Months | 60 Months | |||
| SECONDARY | Overall Survival | 72 months | |||
| SECONDARY | Time to Next Treatment | 72 months | |||
| SECONDARY | Number of Participants With Treatment Related Adverse Events as Assessed (CTCAE) Version 5.0 | 6 Months | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04273139/outcomes